Results 81 to 90 of about 113,618,068 (200)

Diagnostic Value Of Cea, Ca-19-9, Ca 125 And Ca 15-3 Levels In Malignant Pleural Fluids [PDF]

open access: yes, 2009
Aim: Pleural effusion is a common diagnostic problem. Tumor marker levels in pleural effusion may be help to distinguish pleural malignancy, but the precise diagnostic value of these markers remains unclear.
Zamani, Adil   +3 more
core  

Thiol-mediated electrochemical sensor for the breast cancer biomarker CA 15-3

open access: yesFrontiers in Sensors
Cancer antigen 15-3 (CA 15-3), a circulating fragment of the MUC1 glycoprotein, is widely used for monitoring breast cancer progression. In this study, we report a label-free, receptor-free electrochemical detection strategy based on adsorption-mediated ...
Nastaran Ghaffari, Priscilla Baker
doaj   +1 more source

Combined use of CA 125 and CA 15-3 in patients with endometrial carcinoma

open access: yes, 1994
Serum levels of CA 125 and CA 15-3 were measured in 148 patients with primary endometrial carcinoma. CA 125-positive levels were found in 33 and 22% of the cases using a cutoff of 35 and 65 U/ml, respectively.
G. Ferrandina   +9 more
core   +1 more source

Unveiling the Diagnostic Significance of Calprotectin in Serous Ovarian Carcinoma

open access: yesLife
Introduction: Ovarian cancer (OC) is one of the most common gynecologic malignancies and has the highest mortality rate among them. OC has a multifactorial pathogenesis and is characterized by silent onset, progression, and late-stage detection ...
Alkis Matsas   +10 more
doaj   +1 more source

The Investigation of CA 15-3 Antigen Levels in Local and Immigrant Women Patients Diagnosed with Breast Cancer in Gaziantep

open access: yesZeugma Biological Science
Breast cancer is the most prevalent cancer type among women globally and in Turkey. CA 15-3, a mucin antigen derived from the MUC1 gene, serves as a significant biomarker in the diagnosis and monitoring of breast cancer. The aim of this study was to compare CA 15-3 antigen levels in breast cancer patients in Turkey based on variables such as age ...
Mehmet Aydın DAĞDEVIREN   +1 more
openaire   +1 more source

The tetrad BMI, leptin, leptin/adiponectin (L/A) ratio and CA 15-3 is a reliable biomarker of breast cancer. [PDF]

open access: yes, 2013
Background: Several studies have reported that leptin levels, the leptin/adiponectin (L/A) ratio and carbohydrate antigen (CA) 15-3 are especially elevated in breast cancer patients with high body mass index (BMI).
SANTILLAN BENITEZ, JONNATHAN GUADALUPE   +11 more
core  

Relationship between hormone receptors, MIB-1 index and serum tumour markers CEA and CA 15-3 in patients with pT1-2 breast cancer

open access: yes, 2010
Background: CEA and CA 15−3 are the best investigated serum tumor markers in breast cancer (BC) patients. The aim of this study was to find relationship between serum CEA and CA 15−3 and prognostic markers, such estrogen receptor (ER), progesterone ...
LUMACHI, FRANCO   +9 more
core   +1 more source

The Relationship of Tumor Marker Panel with Tumor Size and Histopathological Results in Borderline Ovarian Tumor

open access: yesBezmiâlem Science
Objective: This retrospective, cross-sectional, and single-center study aimed to explore the correlation between preoperative tumor marker panel levels, tumor size, and histopathological features in borderline ovarian tumors (BOTs). Methods: Sixty-seven
Canan SATIR ÖZEL   +4 more
doaj   +1 more source

Urokinase plasminogen activator receptor, plasminogen activator inhibitor- 1,extracellular matrix metalloproteinase protein inducer and CA 15-3 as potential biomarkers for diagnosis and prognosis of primary breast cancer

open access: yes, 2017
Breast cancer is one of the most important leading causes of cancer deathin the less developed countries.The identification of markers that could assist in diagnosis, evaluation of therapeutic response, detection of recurrence and metastasis is a useful ...
Hammad, Wafaa A   +4 more
core   +1 more source

[Tumor markers in the early diagnosis of recurrence in gynecologic neoplasms: combined determination of CA-125, CA 15-3, CA 72.4, SCC, 90 K]

open access: yes, 1991
In 156 patients with gynecologic neoplasia the sieric levels of tumor markers (CA 125, CA 15-3, CA 72.4, SCC and 90 K) before the primary treatment and during the follow-up have been evaluated.
Romanini, C.   +8 more
core  

Home - About - Disclaimer - Privacy